Advanced Search

Technical Analysis for MRNA - Moderna, Inc.

Grade Last Price % Change Price Change
grade A 34.84 4.94% 1.64
MRNA closed up 4.94 percent on Friday, April 3, 2020, on approximately normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
31 Watchers
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Up Up Up
Historical MRNA trend table...
Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Pocket Pivot Bullish Swing Setup 0.00%
Stochastic Reached Overbought Strength 0.00%
Wide Bands Range Expansion 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 4.94%
180 Bullish Setup Bullish Swing Setup 4.94%
Pocket Pivot Bullish Swing Setup 4.94%
Older EOD signals for MRNA ...
View Intraday Alerts

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Track My Stocks
Configure default chart indicators
MRNA Chart by TradingView
Basic chart:

Profile

Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Cancer Life Sciences Biology Coronavirus RNA Messenger RNA

Is MRNA a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Apr 3 Pharma Coronavirus Efforts Continue, Amgen & Incyte Join In
Apr 3 Global Coronavirus Cases Surge Past 1M, Medical Equipment Remains In Shortage
Apr 3 Moderna Coronavirus Vaccine Phase 2 Trials Could Start In Spring, Chairman Says
Apr 2 Recovering From the Coma
Apr 2 Moderna up 11% on encouraging study timeline for COVID-19 vaccine
Apr 2 The Zacks Analyst Blog Highlights: Moderna, Regeneron, Zoom Video, Netflix and Peloton
Apr 2 Coronavirus Vaccine Race Intensifies: 3 Stocks in Focus
Apr 2 With $1.1B in hand, life sciences investor Flagship rewrites its rulebook
Apr 2 Wall Street Breakfast: Record Spike In Jobless Claims
Apr 2 Vaccine 'ultimate game changer' as deaths cross 5,000
See more MRNA news...

Indicators

Indicator Value
52 Week High 36.0
52 Week Low 11.54
Average Volume 15,843,449
200-Day Moving Average 18.53
50-Day Moving Average 24.56
20-Day Moving Average 27.61
10-Day Moving Average 29.57
Average True Range 3.47
ADX 37.16
+DI 32.48
-DI 9.79
Chandelier Exit (Long, 3 ATRs ) 25.25
Chandelier Exit (Short, 3 ATRs ) 29.72
Upper Bollinger Band 34.72
Lower Bollinger Band 20.50
Percent B (%b) 1.01
BandWidth 51.53
MACD Line 2.20
MACD Signal Line 1.67
MACD Histogram 0.5258
Fundamentals Value
Market Cap 318.29 Million
Num Shares 9.14 Million
EPS -3.84
Price-to-Earnings (P/E) Ratio -9.07
Price-to-Sales 4.85
Price-to-Book 0.47
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 39.25
Resistance 3 (R3) 39.03 37.35 38.52
Resistance 2 (R2) 37.35 36.22 37.46 38.27
Resistance 1 (R1) 36.09 35.53 36.72 36.31 38.02
Pivot Point 34.41 34.41 34.72 34.52 34.41
Support 1 (S1) 33.15 33.28 33.78 33.37 31.66
Support 2 (S2) 31.47 32.59 31.58 31.41
Support 3 (S3) 30.21 31.47 31.17
Support 4 (S4) 30.43